Squarepoint Ops LLC Cytosorbents Corp Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.79 - $4.17 $20,334 - $47,371	11,360 New	11,360 $38,000
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $42,563 - $62,515	-14,779 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $59,854 - $119,857	14,779 New	14,779 $62,000
Q3 2020 Nov 16, 2020	SELL	$7.37 - $11.54 $625,145 - $978,857	-84,823 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $532,688 - $898,275	84,823 New	84,823 $840,000
Q1 2020 May 15, 2020	SELL	$3.77 - $7.73 $75,577 - $154,963	-20,047 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $72,369 - $104,645	20,047 New	20,047 $77,000

16.7M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $45.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.